PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35608154-0	2022	MiR-223-3p alleviates trigeminal neuropathic pain in the male mouse by targeting MKNK2 and MAPK/ERK signaling.	mir-223-3p	0-10	MAP kinase-interacting serine/threonine kinase 2	Mus musculus	81-86	
35608154-8	2022	The relationship between miR-223-3p and MKNK2 was tested by a luciferase reporter assay.	mir-223-3p	25-35	MAP kinase-interacting serine/threonine kinase 2	Mus musculus	40-45	
35608154-13	2022	CONCLUSIONS: Overall, miR-223-3p attenuates the development of TN by targeting MKNK2 to suppress MAPK/ERK signaling.	mir-223-3p	22-32	MAP kinase-interacting serine/threonine kinase 2	Mus musculus	79-84